Product Portfolio

Product Portfolio

Meda has a well-diversified product portfolio, a global presence, and is represented within several therapy areas. Prescription drugs account for around 73% of sales while OTC drugs account for 24%. 

Meda's products fall within several therapy areas but the main focus is respiratory and dermatology. In 2013, products in these two therapy areas accounted for 42% of total sales.

For additional information about Meda's products and their availability see each country's local website.

Sales by Product Area

Sales by Therapy Area

This website is intended for people seeking information on Meda AB's Global operations.
We also have national marketing sites. Links to these are under Meda Worldwide at the top of the page.